Citi Pharma Submits Offer to Acquire Leading Pakistani Pharmaceutical Company

Citi Pharma Limited has submitted a non-binding offer for the potential acquisition of a leading pharmaceutical company in Pakistan, according to a notification sent to the Pakistan Stock Exchange (PSX) on April 16, 2025. In a notification, Citi Pharma stated, “The submission of the non-binding offer is part of our ongoing strategic expansion plans of the Company to become one of the largest players in the pharma industry of Pakistan.” The company, however, did not disclose the name of the target pharmaceutical firm or the financial details of the proposed acquisition. Citi Pharma emphasized that any further developments would be subject to the outcome of the due diligence process and subsequent approvals by the Board of Directors and relevant regulatory authorities.